Regeneron, Bayer offer more promising data for aging eye drug
Bayer AG and Regeneron Pharmaceuticals Inc.’s blockbuster eye drug reached another clinical milestone by showing sustained efficacy in trials that could help the companies push back against a competing product from Roche Holding AG.
Tribune News Service ·